BioAtla (BCAB) Interest & Investment Income (2020 - 2026)
BioAtla (BCAB) recorded Interest & Investment Income of $16,000 in Q2 2026, down 93.1% from $233,000 a year earlier and down 56.8% from the prior quarter.
BioAtla (BCAB) Interest & Investment Income (2020 - 2026) Analysis & Trends
On a TTM basis, BioAtla's Interest & Investment Income came in at $259,000 as of Jun 30, 2026, down 86.2% year-over-year; for FY2025, it came in at $843,000, down 75.0% from FY2024.
- Annual Interest & Investment Income has a five-year compound annual growth rate of 53.2% (FY2020 to FY2025).
- Across earlier years, Interest & Investment Income came in at $3.37 million in FY2024 (-46.6%), $6.31 million in FY2023 (+283.0%), $1.65 million in FY2022 (+370.9%) and $350,000 in FY2021 (+250.0%).
- The Q2 2026 figure is the lowest quarterly Interest & Investment Income since Q2 2020.
- On a year-over-year basis, Interest & Investment Income has declined for ten consecutive quarters, with an average decline of 77.4% over the last eight quarters.
- Peak year-over-year performance for Interest & Investment Income in the last five years was growth of 990.6% in Q4 2022, against a decline of 93.1% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $37,000 (Q1 2026), $73,000 (Q4 2025) and $133,000 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | BioAtla | 2.74 Mn | 2.74 Mn | - | 16,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16,000.00 |
| Mar 31, 2026 | 37,000.00 |
| Dec 31, 2025 | 73,000.00 |
| Sep 30, 2025 | 133,000.00 |
| Jun 30, 2025 | 233,000.00 |
| Mar 31, 2025 | 400,000.00 |
| Dec 31, 2024 | 554,000.00 |
| Sep 30, 2024 | 692,000.00 |
| Jun 30, 2024 | 900,000.00 |
| Mar 31, 2024 | 1.22 Mn |
| Dec 31, 2023 | 1.64 Mn |
| Sep 30, 2023 | 1.73 Mn |
| Jun 30, 2023 | 1.46 Mn |
| Mar 31, 2023 | 1.48 Mn |
| Dec 31, 2022 | 1.05 Mn |
| Sep 30, 2022 | 370,000.00 |
| Jun 30, 2022 | 146,000.00 |
| Mar 31, 2022 | 85,000.00 |
| Dec 31, 2021 | 96,000.00 |
| Sep 30, 2021 | 76,000.00 |
BioAtla Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=BCAB&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "BCAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=BCAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();